Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	8.81	32.38	29.76
Graham Fair Price	-7.26	24.72	26.66
PEG	-143.61	-1.26	-0.52
Price/Book	1.94	2.14	2.10
Price/Cash Flow	338.17	180.39	41.17
Prices/Earnings	11.37	14.54	13.06
Price/Sales	9.95	1.95	1.77
Price/FCF	338.17	180.39	41.17
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-4.11	0.13	0.14
Operating Margin	-7.43	0.05	0.05
ROA	-12.33	0.01	0.01
ROE	0.04	0.04	-8.47
ROIC	0.03	0.02	-12.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-437.83
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.24	-0.17	30.92
EPS QOQ	-0.25	-0.12	54.29
FCF QOQ	2.85	-0.77	-72.79
Revenue QOQ	< 0.005	-0.10	-1103.34
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	45.40	49.69	9.45
Days Sales Outstanding (DSO)	28.06	29.75	6.03
Inventory Turnover	1.98	1.81	-8.63
Debt/Capitalization	0.45	0.46	1.81
Quick Ratio	0.53	0.50	-5.15
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	28.01	27.15	-3.07
Cash	7.57	8.10	6.90
Capex	-1.53	-1.20	22.03
Free Cash Flow	1.43	0.32	-77.45
Revenue	33.23	29.86	-10.13
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.01	0.96	-5.18
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.00	7.76	10.83
Naive Interpretation	Member

06 - Financial Health · Bad

Rating